Successfully merged with Liminatus Pharma, LLC • Now trading as IRAA
SPAC Overview
$276M
IPO Size
$2M
Trust (as of 2024-12-31)
Completed
Current Status
2021
IPO Year
Timeline Progress
- Registration2020-12-21 Filed S1
- IPO2021-03-08 IPO, search begins
- Definitive Agreement2022-11-30 Agreement for merger
- Completed2025-03-05 Merger Completed
About
Tribe Capital Growth Corp I is a blank-check company seeking to combine with a top-decile private technology company experiencing a growth inflection point. It plans to apply its sponsor team's venture-capital and data-science experience to identify and support such a business.
Investment Focus
Technology
The terms and the filing trail behind Tribe Capital Growth Corp I
What the sponsor registered, what the deal actually priced at, and every 8-K that moved it — unit structure, sponsor promote, and the dated lifecycle events, each linked to its filing.
- Unit structure as registered and as priced — price, warrant coverage, rights, trust per unit
- Sponsor promote: founder shares and percentage, private-placement warrants, trust deposit
- The full 8-K lifecycle timeline, each event linked to its filing
- Price history across the unit, share and warrant tickers
- Follow it, and see it change on your watchlist
SPAC Team
Sponsors
Leadership
Arjun Sethi
Chairman of the Board of Directors, Chief Executive Officer
Sumit Mehta
Vice President
Omar Ali Chohan
Chief Financial Officer
Theodore Maidenberg
Secretary
Duriya M. Farooqui
Director
Gregg Smith
Independent Director Nominee
Henry S. Ward
Director, Independent Director Nominee
Richard N. Peretz
Director, Independent Director Nominee
Rohit Nanani
Director, Director Nominee
Underwriters
Extended Team Information
The team includes Tribe Capital Management co-founders and investors with experience at Facebook, Slack, Carta, Social Capital and Yahoo, alongside Arrow Capital leaders with international finance and investment experience.
Key Information
IPO Date
2021-03-08
Total Redemptions
$686K
PIPE
$15M
State of Incorporation
DE
SIC
6770
Completion Date
2025-03-05
Merger Target
Liminatus Pharma, LLC
SPAC Ticker
ATVC
Merged Ticker
IRAA